Citation Impact
Citing Papers
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States
2013
Acute hepatitis C and HIV coinfection
2009
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Management of Hepatic Complications in HIV‐Infected Persons
2008
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C
2017
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Molecular assays for monitoring HIV infection and antiretroviral therapy
2007
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Viral Population Estimation Using Pyrosequencing
2008
Acute hepatitis C: Current status and remaining challenges
2008
Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection
2018
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
2009
Association of tenofovir exposure with kidney disease risk in HIV infection
2012
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
2011 Standout
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
2010 Standout
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
2020 Standout
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
2010
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
2010
Recent developments in HIV and the kidney
2008
Do children infected with HIV receiving HAART need to be revaccinated?
2010
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
2008
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey
2007
Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network
2007
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?
2014
Acute Hepatitis C: A Systematic Review.
2008
Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent Patients
2008
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Evaluation of antiretrovirals in animal models of HIV infection
2009
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients
2008
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)
2020
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
2008
Point-of-Care Diagnostics for Global Health
2008 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection
2016
Works of Knud Schewe being referenced
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort
2009
Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks
2009
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients
2007
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years
2007
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients
2020
High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM
2013
Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)
2016
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters
2005
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection
2018
Pegylated Interferon-α for the Treatment of Sexually Transmitted Acute Hepatitis C in HIV-Infected Individuals
2006